GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

CDR-404 is under clinical development by CDR-Life and currently in Phase I for Squamous Non-Small Cell Lung Cancer.

The early detection of cancer in patients in Sussex has risen to its highest ever level, according to new NHS analysis. Of ...

Edgardo S. Santos, MD, FACP, FASCO, discussed the barriers to precision medicine in lung cancer treatment, including patient ...

Ian Smith is reflecting on 'good news' in his battle against terminal lung cancer.The Neighbours legend, who announced his ...